EFTA00036892.pdf
16.6 KB
Extraction Summary
2
People
3
Organizations
2
Locations
1
Events
1
Relationships
3
Quotes
Document Information
Type:
Email correspondence
File Size:
16.6 KB
Summary
An email chain from August 12, 2019, between the Associate Warden and staff at MCC New York. The correspondence discusses updating a policy 'Supplement' to include protocols for Naloxone (an opioid overdose reversal drug) rather than creating a separate document. This discussion takes place two days after Jeffrey Epstein's death at the facility.
Organizations (3)
Timeline (1 events)
2019-08-12
Internal review of prison protocols (Supplement) regarding Naloxone usage at MCC New York, occurring two days after Jeffrey Epstein's death.
MCC New York
Associate Warden
MCC Staff
Locations (2)
| Location | Context |
|---|---|
Relationships (1)
Associate Warden
→
Professional/Colleagues
→
REDACTED Recipient
Internal email correspondence regarding institutional policy.
Key Quotes (3)
"We need to find time to review the attached Supplement to ensure it is up to date."Source
EFTA00036892.pdf
Quote #1
"I would like to add the Naloxone in it instead of creating a new Supplement just for Naloxone."Source
EFTA00036892.pdf
Quote #2
"This is what the other institutions have done."Source
EFTA00036892.pdf
Quote #3
Full Extracted Text
Complete text extracted from the document (441 characters)
Good Morning,
We need to find time to review the attached Supplement to ensure it is up to date. I would like to add the Naloxone in it
instead of creating a new Supplement just for Naloxone. This is what the other institutions have done. Your thoughts?
Thanks.
instead of creating a new Supplement just for Naloxone. This is what the other institutions have done. Your thoughts?
Thanks.
[REDACTED]
Associate Warden
MCC New York
[REDACTED]
New York, New York 10007
[REDACTED]
Associate Warden
MCC New York
[REDACTED]
New York, New York 10007
[REDACTED]
>>> [REDACTED] 8/12/2019 10:54 AM >>>
Please see the attached.
Please see the attached.
[REDACTED]
EFTA00036892
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document